UB Paderborn / Katalog / Suche / in CDI

Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project

Annals of oncology, 2019-08, Vol.30 (8), p.1304-1310

2019

Volltextzugriff (PDF)

Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC)

British journal of cancer, 2012-01, Vol.106 (3), p.453-459

2012

Volltextzugriff (PDF)

Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG)

Cancer chemotherapy and pharmacology, 2016-08, Vol.78 (2), p.369-376

2016

Volltextzugriff (PDF)

87P Real-world evidence of FTD/TPI and bevacizumab combination therapy in metastatic colorectal cancer: Survival and clinicopathological insights

Annals of oncology, 2024-06, Vol.35, p.S42-S43

2024

Volltextzugriff (PDF)

1818MO Can thromboprophylaxis build a link for cancer patients undergoing surgical and/or chemotherapy treatment? Intermediate results from the MeTHOS study

Annals of oncology, 2020-09, Vol.31, p.S1049-S1050

2020

Volltextzugriff (PDF)

P-50 RETRO-TAS, a retrospective observational study of rifluridine/tipiracil in chemorefractory metastatic colorectal cancer

Annals of oncology, 2022-06, Vol.33, p.S264

2022

Volltextzugriff (PDF)

Current concepts on GIST: Imatinib: One size does not fit all

Hellenic journal of surgery, 2017-04, Vol.89 (2), p.68-70

2017

Volltextzugriff (PDF)

PCN94 Cost-Effectiveness of Trifluridine/Tipiracil (FTD/TPI) As a Third-LINE Treatment of Metastatic Gastric Cancer, Including Adenocarcinoma of the Gastroesophageal Junction, Among Patients WHO Have Received at Least Two PRIOR Therapies for Metastatic Disease in Greece

Value in health, 2020-12, Vol.23, p.S439-S439

2020

Volltextzugriff (PDF)

PCN57 Budget IMPACT Analysis of Trifluridine/Tipiracil (FTD/TPI) As a Third-LINE Treatment of Metastatic Gastric Cancer, Including Adenocarcinoma of the Gastroesophageal Junction, Among Patients WHO Have Received at Least Two PRIOR Therapies for Metastatic Disease in Greece

Value in health, 2020-12, Vol.23, p.S431-S432

2020

Volltextzugriff (PDF)

CAPIRI plus bevacizumab (CAPIRI-B) versus FOLFIRI plus bevacizumab (FOLFIRI-B) for the treatment of patients with metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.3542-3542

2010

Volltextzugriff (PDF)

1252 Ondansetron (ODS) + metoclopramide (MTP) + dexamethasone (DXM) vs Ondansetron + dexamethasone during CDDP based chemotherapy (CT)

European journal of cancer (1990), 1995-11, Vol.31, p.S261-S261

1995

Volltextzugriff (PDF)

790 Evaluation of six serum tumour markers in patients with non-small cell lung cancer

European journal of cancer supplements, 2003-09, Vol.1 (5), p.S237-S238

2003

Volltextzugriff (PDF)

149 Phase II study of taxotere monotherapy in non small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.40-40

1997

Volltextzugriff (PDF)

Excimer laser electrode extraction in the presence of a leadless pacemaker: a case report

Clinical research in cardiology, 2024-10, Vol.113 (10), p.1501-1504

2024

Volltextzugriff (PDF)

Postcardiac injury syndrome after cardiac implantable electronic device implantation

Herz, 2020-11, Vol.45 (7), p.696-702

2020

Volltextzugriff (PDF)

Effects of Ionizing Radiation on Cardiac Implantable Electronic Devices (CIEDs) in Patients with Esophageal Cancer Undergoing Radiotherapy: A Pilot Study

Cancers, 2024-01, Vol.16 (3), p.555

2024

Volltextzugriff (PDF)

Cryoballoon pulmonary vein isolation-mediated rise of sinus rate in patients with paroxysmal atrial fibrillation

Clinical research in cardiology, 2021-01, Vol.110 (1), p.124-135

2021

Volltextzugriff (PDF)

Verapamil inhibits Kir2.3 channels by binding to the pore and interfering with PIP2 binding

Naunyn-Schmiedeberg's archives of pharmacology, 2023-04, Vol.396 (4), p.659-667

2023

Volltextzugriff (PDF)

Can thromboprophylaxis build a link for cancer patients undergoing surgical and/or chemotherapy treatment? The MeTHOS cohort study

Supportive care in cancer, 2022-08, Vol.30 (8), p.6973-6984

2022

Volltextzugriff (PDF)

Inhibition of Cardiac Kir Current (IK1) by Protein Kinase C Critically Depends on PKCβ and Kir2.2

PloS one, 2016-05, Vol.11 (5), p.e0156181-e0156181

2016

Volltextzugriff (PDF)

Cost-effectiveness of trifluridine/tipiracil as a third-line treatment of metastatic gastric cancer, including adenocarcinoma of the gastrohesophageal junction, among patients previously treated in Greece

Expert review of pharmacoeconomics & outcomes research, 2022-02, Vol.22 (2), p.259-269

2022

Volltextzugriff (PDF)

RETRO-TAS, a Retrospective Observational Study of Trifluridine/Tipiracil in Chemorefractory Metastatic Colorectal Cancer

Biomedicines, 2023-04, Vol.11 (5), p.1267

2023

Volltextzugriff (PDF)

The Importance of Detecting the Signs of Primary Hyperoxaluria—Cardiac Oxalosis in Primary Hyperoxaluria Type 1

Annals of Internal Medicine: Clinical Cases, 2024-02, Vol.3 (2)

2024

Volltextzugriff (PDF)

Genetic Predisposition to Male Breast Cancer: A Case Series

Anticancer research, 2022-12, Vol.42 (12), p.5795-5801

2022

Volltextzugriff (PDF)

Akzeptanz einer telemetrischen Versorgung bei Patienten mit sICD-Sicherheitshinweis: Qualitative Interviewstudie der kardiologischen Versorgungsforschung

Herzschrittmachertherapie & Elektrophysiologie, 2023-01, Vol.34 (2), p.136-141

2023

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project

Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC)

Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG)

87P Real-world evidence of FTD/TPI and bevacizumab combination therapy in metastatic colorectal cancer: Survival and clinicopathological insights

1818MO Can thromboprophylaxis build a link for cancer patients undergoing surgical and/or chemotherapy treatment? Intermediate results from the MeTHOS study

P-50 RETRO-TAS, a retrospective observational study of rifluridine/tipiracil in chemorefractory metastatic colorectal cancer

Current concepts on GIST: Imatinib: One size does not fit all

PCN94 Cost-Effectiveness of Trifluridine/Tipiracil (FTD/TPI) As a Third-LINE Treatment of Metastatic Gastric Cancer, Including Adenocarcinoma of the Gastroesophageal Junction, Among Patients WHO Have Received at Least Two PRIOR Therapies for Metastatic Disease in Greece

PCN57 Budget IMPACT Analysis of Trifluridine/Tipiracil (FTD/TPI) As a Third-LINE Treatment of Metastatic Gastric Cancer, Including Adenocarcinoma of the Gastroesophageal Junction, Among Patients WHO Have Received at Least Two PRIOR Therapies for Metastatic Disease in Greece

CAPIRI plus bevacizumab (CAPIRI-B) versus FOLFIRI plus bevacizumab (FOLFIRI-B) for the treatment of patients with metastatic colorectal cancer (mCRC)

1252 Ondansetron (ODS) + metoclopramide (MTP) + dexamethasone (DXM) vs Ondansetron + dexamethasone during CDDP based chemotherapy (CT)

790 Evaluation of six serum tumour markers in patients with non-small cell lung cancer

149 Phase II study of taxotere monotherapy in non small cell lung cancer (NSCLC)

Excimer laser electrode extraction in the presence of a leadless pacemaker: a case report

Postcardiac injury syndrome after cardiac implantable electronic device implantation

Effects of Ionizing Radiation on Cardiac Implantable Electronic Devices (CIEDs) in Patients with Esophageal Cancer Undergoing Radiotherapy: A Pilot Study

Cryoballoon pulmonary vein isolation-mediated rise of sinus rate in patients with paroxysmal atrial fibrillation

Verapamil inhibits Kir2.3 channels by binding to the pore and interfering with PIP2 binding

Can thromboprophylaxis build a link for cancer patients undergoing surgical and/or chemotherapy treatment? The MeTHOS cohort study

Inhibition of Cardiac Kir Current (IK1) by Protein Kinase C Critically Depends on PKCβ and Kir2.2

Cost-effectiveness of trifluridine/tipiracil as a third-line treatment of metastatic gastric cancer, including adenocarcinoma of the gastrohesophageal junction, among patients previously treated in Greece

RETRO-TAS, a Retrospective Observational Study of Trifluridine/Tipiracil in Chemorefractory Metastatic Colorectal Cancer

The Importance of Detecting the Signs of Primary Hyperoxaluria—Cardiac Oxalosis in Primary Hyperoxaluria Type 1

Genetic Predisposition to Male Breast Cancer: A Case Series

Akzeptanz einer telemetrischen Versorgung bei Patienten mit sICD-Sicherheitshinweis: Qualitative Interviewstudie der kardiologischen Versorgungsforschung

Suchergebnisse filtern